{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:03:36Z","timestamp":1793192616575,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11046-026-01063-8","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:14:23Z","timestamp":1773994463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Candidemia Attributed to a Urinary Tract Source: Retrospective Cohort Study of Risk Factors, Clinical Profiles, Therapeutic Approaches and Outcomes"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-2559","authenticated-orcid":false,"given":"Alejandro","family":"D\u00edez-Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"L\u00f3pez De Coca Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grandioso-Vas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mart\u00ednez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Marcelo-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-3597","authenticated-orcid":false,"given":"Carlos","family":"O\u00f1oro-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-8766","authenticated-orcid":false,"given":"Alejandro","family":"De Gea Grela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Gloria","family":"Torres Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Cendejas-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7241-4208","authenticated-orcid":false,"given":"Beatriz","family":"D\u00edaz-Poll\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"2","key":"1063_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.idc.2021.03.007","volume":"35","author":"TP McCarty","year":"2021","unstructured":"McCarty TP, White CM, Pappas PG. Candidemia and invasive candidiasis. Infect Dis Clin North Am. 2021;35(2):389\u2013413. https:\/\/doi.org\/10.1016\/j.idc.2021.03.007.","journal-title":"Infect Dis Clin North Am"},{"key":"1063_CR2","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.2147\/IDR.S274872","volume":"14","author":"AM Tortorano","year":"2021","unstructured":"Tortorano AM, Prigitano A, Morroni G, Brescini L, Barchiesi F. Candidemia: evolution of drug resistance and novel therapeutic approaches. Infect Drug Resist. 2021;14:5543\u201353. https:\/\/doi.org\/10.2147\/IDR.S274872.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"1063_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"C Lass-Fl\u00f6rl","year":"2024","unstructured":"Lass-Fl\u00f6rl C, Kanj SJ, Govender NP, Thompson GR 3rd, Ostrosky-Zeichner L, Govrins MA. Invasive candidiasis. Nat Rev Dis Primers. 2024;10(1):20. https:\/\/doi.org\/10.1038\/s41572-024-00503-3.","journal-title":"Nat Rev Dis Primers"},{"key":"1063_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","volume":"1508","author":"DA Enoch","year":"2017","unstructured":"Enoch DA, Yang H, Aliyu SH, Micallef C. The changing epidemiology of invasive fungal infections. Methods Mol Biol. 2017;1508:17\u201365. https:\/\/doi.org\/10.1007\/978-1-4939-6515-1_2.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1063_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2021.101210","volume":"32","author":"M Vannini","year":"2022","unstructured":"Vannini M, Emery S, Lieutier-Colas F, et al. Epidemiology of candidemia in NICE area, France: a five-year study of antifungal susceptibility and mortality. J Mycol Med. 2022;32(1):101210. https:\/\/doi.org\/10.1016\/j.mycmed.2021.101210.","journal-title":"J Mycol Med"},{"issue":"2-3","key":"1063_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11046-022-00624-x","volume":"187","author":"L Brescini","year":"2022","unstructured":"Brescini L, Mazzanti S, Morroni G, et al. Candidemia in internal medicine: facing the new challenge. Mycopathologia. 2022;187(2\u20133):181\u20138. https:\/\/doi.org\/10.1007\/s11046-022-00624-x.","journal-title":"Mycopathologia"},{"issue":"8","key":"1063_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12081597","volume":"12","author":"G Scaglione","year":"2024","unstructured":"Scaglione G, Colaneri M, Offer M, et al. Epidemiology and clinical insights of catheter-related candidemia in Non-ICU patients with vascular access devices. Microorganisms. 2024;12(8):1597. https:\/\/doi.org\/10.3390\/microorganisms12081597.","journal-title":"Microorganisms"},{"issue":"11","key":"1063_CR8","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00345-019-02991-5","volume":"38","author":"Z Odabasi","year":"2020","unstructured":"Odabasi Z, Mert A. Candida urinary tract infections in adults. World J Urol. 2020;38(11):2699\u2013707. https:\/\/doi.org\/10.1007\/s00345-019-02991-5.","journal-title":"World J Urol"},{"issue":"4","key":"1063_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.idc.2021.08.003","volume":"35","author":"CE Chenoweth","year":"2021","unstructured":"Chenoweth CE. Urinary tract infections: 2021 update. Infect Dis Clin North Am. 2021;35(4):857\u201370. https:\/\/doi.org\/10.1016\/j.idc.2021.08.003.","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"1063_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ucl.2024.06.006","volume":"51","author":"RA Stubbee","year":"2024","unstructured":"Stubbee RA, Orzel J, Tracy CR. Best practices in treatment of fungal urinary tract infections. Urol Clin North Am. 2024;51(4):483\u201392. https:\/\/doi.org\/10.1016\/j.ucl.2024.06.006.","journal-title":"Urol Clin North Am"},{"issue":"1","key":"1063_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10096-020-03999-1","volume":"40","author":"Z He","year":"2021","unstructured":"He Z, Huo X, Lei D, Zhao H, Jia K, Wang F. Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions. Eur J Clin Microbiol Infect Dis. 2021;40(1):59\u201365. https:\/\/doi.org\/10.1007\/s10096-020-03999-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"1063_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2022.101353","volume":"33","author":"A Chaari","year":"2023","unstructured":"Chaari A, Munir A, Sharaf A, Khairy A, Kauts V, Erdem H. Predictive factors and prognostic value of candiduria in critically-ill patients with solid and hematological malignancies. J Mycol Med. 2023;33(1):101353. https:\/\/doi.org\/10.1016\/j.mycmed.2022.101353.","journal-title":"J Mycol Med"},{"issue":"4","key":"1063_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2174\/1389557521666210805112416","volume":"22","author":"AK Estrada","year":"2022","unstructured":"Estrada AK, Delgado-Maldonado T, Lara-Ram\u00edrez EE, et al. Recent advances in the development of Type 2 Sodium-Glucose Cotransporter Inhibitors for the treatment of Type 2 Diabetes Mellitus. Mini Rev Med Chem. 2022;22(4):586\u201399. https:\/\/doi.org\/10.2174\/1389557521666210805112416.","journal-title":"Mini Rev Med Chem"},{"key":"1063_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","volume":"83","author":"V Vallon","year":"2021","unstructured":"Vallon V, Verma S. Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol. 2021;83:503\u201328. https:\/\/doi.org\/10.1146\/annurev-physiol-031620-095920.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"1063_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","volume":"6","author":"DK McGuire","year":"2021","unstructured":"McGuire DK, Shih WJ, Cosentino F, et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiol. 2021;6(2):148\u201358. https:\/\/doi.org\/10.1001\/jamacardio.2020.4511.","journal-title":"JAMA Cardiol"},{"issue":"8","key":"1063_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jiac.2021.05.012","volume":"27","author":"J Kamei","year":"2021","unstructured":"Kamei J, Yamamoto S. Complicated urinary tract infections with diabetes mellitus. J Infect Chemother. 2021;27(8):1131\u20136. https:\/\/doi.org\/10.1016\/j.jiac.2021.05.012.","journal-title":"J Infect Chemother"},{"issue":"5","key":"1063_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11892-024-01537-3","volume":"24","author":"R Pishdad","year":"2024","unstructured":"Pishdad R, Auwaerter PG, Kalyani RR. Diabetes, SGLT-2 inhibitors, and urinary tract infection: a review. Curr Diab Rep. 2024;24(5):108\u201317. https:\/\/doi.org\/10.1007\/s11892-024-01537-3.","journal-title":"Curr Diab Rep"},{"issue":"3","key":"1063_CR18","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/j.amjmed.2023.10.036","volume":"137","author":"I Arnaud-Borboa","year":"2024","unstructured":"Arnaud-Borboa I, Sheth M. Do we stop SGLT2 inhibitor after UTI with septic shock? Am J Med. 2024;137(3):e56\u20137. https:\/\/doi.org\/10.1016\/j.amjmed.2023.10.036.","journal-title":"Am J Med"},{"issue":"8","key":"1063_CR19","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1016\/j.amjmed.2022.03.015","volume":"135","author":"T Luu","year":"2022","unstructured":"Luu T, Albarillo FS. Asymptomatic bacteriuria: prevalence, diagnosis, management, and current antimicrobial stewardship implementations. Am J Med. 2022;135(8):e236\u201344. https:\/\/doi.org\/10.1016\/j.amjmed.2022.03.015.","journal-title":"Am J Med"},{"issue":"8","key":"1063_CR20","first-page":"496","volume":"98","author":"DC Serlin","year":"2018","unstructured":"Serlin DC, Heidelbaugh JJ, Stoffel JT. Urinary retention in adults: evaluation and initial management. Am Fam Physician. 2018;98(8):496\u2013503.","journal-title":"Am Fam Physician"},{"issue":"4","key":"1063_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cnur.2018.07.007","volume":"53","author":"S Stevens","year":"2018","unstructured":"Stevens S. Obstructive kidney disease. Nurs Clin North Am. 2018;53(4):569\u201378. https:\/\/doi.org\/10.1016\/j.cnur.2018.07.007.","journal-title":"Nurs Clin North Am"},{"issue":"4","key":"1063_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ93326","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1\u201350. https:\/\/doi.org\/10.1093\/cid\/civ93326.","journal-title":"Clin Infect Dis"},{"key":"1063_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00749-7","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, Sprute R, Bassetti M, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2025. https:\/\/doi.org\/10.1016\/S1473-3099(24)00749-7.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1063_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.mcna.2023.03.002","volume":"107","author":"K Haq","year":"2023","unstructured":"Haq K, Patel DM. Urinalysis: interpretation and clinical correlations. Med Clin North Am. 2023;107(4):659\u201379. https:\/\/doi.org\/10.1016\/j.mcna.2023.03.002.","journal-title":"Med Clin North Am"},{"issue":"11","key":"1063_CR25","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337.","journal-title":"Crit Care Med"},{"issue":"1","key":"1063_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3949\/ccjm.87a.18143","volume":"87","author":"S Dugar","year":"2020","unstructured":"Dugar S, Choudhary C, Duggal A. Sepsis and septic shock: guideline-based management. Cleve Clin J Med. 2020;87(1):53\u201364. https:\/\/doi.org\/10.3949\/ccjm.87a.18143.","journal-title":"Cleve Clin J Med"},{"issue":"8","key":"1063_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/apm.13336","volume":"131","author":"P Jangir","year":"2023","unstructured":"Jangir P, Kalra S, Tanwar S, Bari VK. Azole resistance in Candida auris: mechanisms and combinatorial therapy. APMIS. 2023;131(8):442\u201362. https:\/\/doi.org\/10.1111\/apm.13336.","journal-title":"APMIS"},{"issue":"5","key":"1063_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/MCC.0000000000001077","volume":"29","author":"JA Paiva","year":"2023","unstructured":"Paiva JA, Pereira JM. Treatment of invasive candidiasis in the era of Candida resistance. Curr Opin Crit Care. 2023;29(5):457\u201362. https:\/\/doi.org\/10.1097\/MCC.0000000000001077.","journal-title":"Curr Opin Crit Care"},{"issue":"7","key":"1063_CR29","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028.","journal-title":"Clin Microbiol Infect"},{"key":"1063_CR30","unstructured":"Eraxis (anidulafungin) [prescribing information]. New York, NY: Pfizer Inc; 2023."},{"key":"1063_CR31","unstructured":"Cancidas (caspofungin acetate) [prescribing information]. Whitehouse Station, NJ: Merck & Co., Inc.; 2022."},{"key":"1063_CR32","unstructured":"Mycamine (micafungin sodium) [prescribing information]. Northbrook, IL: Astellas Pharma US, Inc.; 2023."},{"issue":"9","key":"1063_CR33","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/14740338.2021.1922667","volume":"20","author":"A Tragiannidis","year":"2021","unstructured":"Tragiannidis A, Gkampeta A, Vousvouki M, Vasileiou E, Groll AH. Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions. Expert Opin Drug Saf. 2021;20(9):1061\u201374. https:\/\/doi.org\/10.1080\/14740338.2021.1922667.","journal-title":"Expert Opin Drug Saf"},{"key":"1063_CR34","unstructured":"AmBisome (amphotericin B liposome) [prescribing information]. Foster City, CA: Gilead Sciences, Inc.; 2023."},{"issue":"4","key":"1063_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","volume":"76","author":"NR Stone","year":"2016","unstructured":"Stone NR, Bicanic T, Salim R, Hope W. Liposomal Amphotericin B (AmBisome(\u00ae)): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs. 2016;76(4):485\u2013500. https:\/\/doi.org\/10.1007\/s40265-016-0538-7.","journal-title":"Drugs"},{"key":"1063_CR36","unstructured":"Diflucan (fluconazole) [prescribing information]. New York, NY: Pfizer Inc; 2022."},{"issue":"5","key":"1063_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1573399815666191024085838","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442\u20139. https:\/\/doi.org\/10.2174\/1573399815666191024085838.","journal-title":"Curr Diabetes Rev"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-026-01063-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:06:52Z","timestamp":1777280812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-026-01063-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1007\/s11046-026-01063-8","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Table 4 layout has been corrected","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"During the preparation of this article, ChatGPT-5 was used for targeted grammatical and stylistic corrections.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of Artificial Intelligence (AI)"}}],"article-number":"45"}}